Skip Navigation


NDT Advance Access originally published online on October 18, 2006
Nephrology Dialysis Transplantation 2007 22(1):53-58; doi:10.1093/ndt/gfl601
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/1/53    most recent
gfl601v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Van Biesen, W.
Right arrow Articles by Vanholder, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Biesen, W.
Right arrow Articles by Vanholder, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis

Wim Van Biesen, Francio Verbeke and Raymond Vanholder

Renal Division, Department of Internal Medicine, University Hospital Ghent, Belgium

Correspondence and offprint requests to: W. Van Biesen, Renal division, Department of Internal Medicine, University Hospital Ghent, De Pintelaan 185, 9000 Ghent, Belgium. Email: wim.vanbiesen@urgent.be

Keywords: cardiovascular; hemodialysis; outcome; peritoneal dialysis; survival; uraemic toxins

The first 150 words of the full text of this article appear below.



   Introduction
 
Cardiovascular disease is frequent in end-stage renal disease (ESRD) patients, and it is the major cause of morbidity [1,2] and mortality [3] in this population. It can manifest itself as ischaemic heart disease, congestive heart failure, atherosclerotic peripheral vascular disease [4] or cerebrovascular disease [5]. In the last decade, evidence has accrued that part of this cardiovascular damage might be due to renal replacement therapy (RRT) itself, and the question whether haemodialysis (HD) or peritoneal dialysis (PD) is more harmful than the other is, therefore, of high relevance.

Some recent publications have suggested a worse outcome in PD as compared with HD patients [6,7] with congestive heart failure or coronary heart disease, pleading to avoid PD in cardiovascular-compromised patients. Are these results the confirmation that PD is a second-class treatment, or are we listening to the . . . [Full Text of this Article]

Clinical outcome studies
General population studies
Dialysis modality and de novo cardiac disease
Patients with existing cardiovascular disease
Causes of cardiovascular risk in ESRD patients, performance differences between different modes of PD and HD and their relation to impact on cardiovascular outcome
Uraemic retention products, modality and cardiovascular outcome
Volume status, modality and cardiovascular outcome
Inflammation, modality and cardiovascular risk
Traditional cardiovascular risk factors in PD and HD


   Conclusions
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 pdiHome page
J.-H. Liu, H.-H. Lin, Y.-F. Yang, Y.-L. Liu, H.-L. Kuo, I-K. Wang, C.-Y. Chou, and C.-C. Huang
SUBCLINICAL PERIPHERAL ARTERY DISEASE IN PATIENTS UNDERGOING PERITONEAL DIALYSIS: RISK FACTORS AND OUTCOME
Perit. Dial. Int., January 1, 2009; 29(1): 64 - 71.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Krajewska, W. Kosmala, W. Weyde, K. Madziarska, T. Porazko, W. Kopec, R. Klak, J. Penar, M. Kusztal, E. Watorek, et al.
The effect of dialysis modality (PD and HD) on cardiac morphology and functions in chronic kidney disease patients at very high cardiovascular risk
Nephrol. Dial. Transplant., February 1, 2008; 23(2): 768 - 769.
[Full Text] [PDF]